Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin for weight loss in nondiabetic overweight and obese subjects
NCT00650806Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of canagliflozin in obesity, sponsored by Johnson & Johnson. Started May 2008; status: completed.
02
Drugs
canagliflozin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00650806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650806.